Katabi Maha
Insider CIK 1720685 · BOLT 10% owner · INZY 10% owner · AKUS 10% owner · AVTE Director, 10% owner · RYZB Director · VERA Director, 10% owner · CINC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERA Vera Therapeutics, Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2024-05-15 | 2024-05-17 | 14,000 | — | $0 | 14,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-03-25 | 2024-03-25 | 340,000 | $40.50 | $13.77M | 2,793,987 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-03-22 | 2024-03-25 | 413,450 | $40.51 | $16.75M | 3,133,987 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 32,756 | $43.00 | $1.41M | 3,595,690 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 13,718 | $46.18 | $633.5K | 3,547,437 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 12,617 | $45.52 | $574.3K | 3,561,155 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 21,918 | $44.00 | $964.4K | 3,573,772 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer deriv | 2024-02-26 | 2024-02-27 | 18,235 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer | 2024-02-26 | 2024-02-27 | 1,209,764 | $62.50 | $75.61M | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer | 2024-02-26 | 2024-02-27 | 1,209,764 | $62.50 | $75.61M | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2024-01-30 | 2024-02-01 | 161,290 | $31.00 | $5.00M | 3,628,446 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2024-01-02 | 2024-01-04 | 3,519 | $13.49 | $47.5K | 3,519 | SEC↗ |
| RYZB RayzeBio, Inc. | A Award deriv | 2023-11-17 | 2023-11-17 | 18,235 | — | $0 | 18,235 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 973,653 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 973,653 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 973,653 | — | $0 | 973,653 | SEC↗ |
| RYZB RayzeBio, Inc. | P Buy | 2023-09-19 | 2023-09-21 | 236,111 | $18.00 | $4.25M | 1,209,764 | SEC↗ |
| RYZB RayzeBio, Inc. | P Buy | 2023-09-19 | 2023-09-21 | 236,111 | $18.00 | $4.25M | 1,209,764 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 973,653 | — | $0 | 973,653 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2023-05-10 | 2023-05-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 9,803 | — | $0 | 19,608 | SEC↗ |
| CINC CinCor Pharma, Inc. | D To issuer | 2023-02-24 | 2023-02-27 | 19,608 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 6,073,949 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-06 | 2023-02-08 | 285,714 | $7.00 | $2.00M | 3,467,156 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2023-01-03 | 2023-01-05 | 2,627 | $18.08 | $47.5K | 2,627 | SEC↗ |
| CINC CinCor Pharma, Inc. | S Sale | 2022-11-28 | 2023-02-27 | 6,000 | $14.32 | $85.9K | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-11 | 2022-08-15 | 500,000 | $30.00 | $15.00M | 6,073,949 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2022-06-21 | 2022-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2022-05-24 | 2022-05-26 | 9,925 | — | $0 | 9,925 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2022-02-10 | 2022-02-14 | 266,666 | $15.00 | $4.00M | 3,181,442 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 13,571,428 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 4,275,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 5,248,949 | — | $0 | 5,248,949 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 325,000 | $16.00 | $5.20M | 5,573,949 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2022-01-03 | 2022-01-05 | 7,240 | $6.56 | $47.5K | 7,240 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 10,565,238 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | P Buy | 2021-07-02 | 2021-07-06 | 357,142 | $14.00 | $5.00M | 3,758,686 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion | 2021-07-02 | 2021-07-06 | 3,401,544 | — | $0 | 3,401,544 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-07-01 | 2021-07-06 | 2,467 | $11.15 | $27.5K | 2,467 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-06-29 | 2021-07-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-06-04 | 2021-07-01 | 8,082,190 | $1.89 | $15.28M | 10,565,238 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-18 | 2021-05-18 | 727,272 | $11.00 | $8.00M | 2,914,776 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 2,187,504 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2021-05-13 | 2021-05-17 | 9,925 | — | $0 | 9,925 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 2,304,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 450,000 | $20.00 | $9.00M | 2,754,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 1,104,209 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | A Award deriv | 2021-02-01 | 2021-07-01 | 1,164,213 | $1.89 | $2.20M | 2,483,048 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 11,888,112 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 1,590,808 | — | $0 | 1,590,808 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 437,500 | $16.00 | $7.00M | 2,028,308 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 12,643,557 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 18,044,028 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 58,823 | $17.00 | $1000.0K | 1,515,073 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 599,988 | — | $0 | 1,456,250 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 856,262 | — | $0 | 856,262 | SEC↗ |